期刊文献+

多发性骨髓瘤患者cyclinD1的表达及预后意义

原文传递
导出
摘要 多发性骨髓瘤(MM)难以治愈,其预后受多种因素影响。CyclinD1是细胞从G1期到S期的关键蛋白,其表达与MM预后的相关性存在争议。本研究检测了MM患者cyclinD1基因及蛋白表达,观察了cyclinD1蛋白表达与疗效和生存期的关系,明确其预后意义。
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第8期647-648,共2页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献6

  • 1张之南,沈悌.血液病诊断与疗效标准.3版.北京:科学出版社,2007:157-161.
  • 2Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia, 2006,20:1467-1473.
  • 3Soverini S, Cavo M, Cellini C, et al. Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. Blood, 2003,102:1588-1594.
  • 4Bergsagel PL, Kuehl WM, Zhan F, et al. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood, 2005,106:296-303.
  • 5Kuroda Y, Sakai A, Tsuyama N, et al. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma. Int J Oncol, 2008,33:1201-1213.
  • 6Dawson MA, Opat SS, Taouk Y, et al. Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma. Clin Cancer Res, 2009,15:714-722.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部